Hyperplasia of mammary glands
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients meeting the above diagnostic criteria for cyclomastopathy; 2) Non-periodic breast pain, with VAS score (pain visual analogue scale) of =4 points, i.e., moderate to severe pain; 3) Breast ultrasound: breast nodules of BI-RADS grade 2–3 and considered as hyperplasia of mammary glands nodules; 4) Women aged 30–55 years old, with the disease course of 3 months–5 years; Patients with regular menstrual cycles (28±7 days) and menstrual periods (3–7 days); 5) Informed consent form was signed and the participants were volunteers. The informed consent process met the requirements of GCP.
Exclusion criteria
Exclusion criteria: 1) Pregnant or lactating women; 2) Other diseases causing breast pain, such as chest wall pain, gallstones, gastroesophageal reflux disease, cervical radiation pain, angina pectoris, breast abscess, and breast cancer; Breast fibroadenoma, breast cancer and other causes of breast lumps; 3) Those who have received acupuncture and moxibustion treatment within six months or taken hormone drugs to treat breast diseases; 4) Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system as well as mental illness; 5) Those who are intolerant to acupuncture or have a history of acupuncture sickness; 6) patients who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale;Simplified McGill Pain Questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| Maximum nodule volume;The number of breast nodules;Number of Fenbid Tablets taken; | — |
Countries
CHINA
Contacts
Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University